Type 2 & other diabetes

Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

In middle-aged and elderly participants with abnormal glucose metabolism, constant higher AIP with worst control may have a higher incidence of CVD. Monitoring long-term AIP change will contribute to early identification of high risk of CVD among individuals with abnormal glucose metabolism.

Study context

Population
Middle-aged and elderly Chinese participants with abnormal glucose metabolism (diabetes and pre-diabetes), China Health and Retirement Longitudinal Study
Participants
2,659 participants
Exposure
Atherogenic index of plasma (AIP) control level classes 2–5 vs class 1
Outcome
Incident CVD (self-reported heart disease and/or stroke)
Follow-up
Within 3 years
Methodological detailsk-means clustering of AIP control level, multivariable logistic regression, restricted cubic spline analysis
  • K-means clustering of AIP control level
  • Multivariable logistic regression
  • Restricted cubic spline analysis

Main finding

As reported in the abstract

Incident CVD
Adjusted
Each group vs class 1Odds ratio (95% CI)
Class 2
1.31(0.90–1.90)
Class 3
1.38(0.99–1.93)
Class 4
1.46(1.01–2.10)
Class 5
1.56(1.03–2.37)
Participants progressing to cardiovascular disease (CVD)
398 (14.97%)

Observational data: associations, not effects.

Further findings

Dose–response (restricted cubic spline)

Relationship between cumulative AIP index and CVD is linear

Subgroup analysis

Similar results in agricultural Hukou, history of smoking, diastolic BP ≥ 80mmHg and normal BMI subgroups
No interaction between AIP control level and subgroup variables

Original publication

Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism. Cardiovasc Diabetol. Published 8 February 2024. doi:10.1186/s12933-024-02144-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.